Market approval for drugs in the EU: time to change direction? Alessandro CurtoKatelijne van de VoorenLivio Garattini Editorial 27 December 2016 Pages: 933 - 936
The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies Alexandre BaptistaInês TeixeiraJulian Perelman Original Paper 17 October 2016 Pages: 937 - 965
Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale Paul F. M. KrabbeElly A. StolkA. Simon Pickard Original Paper Open access 02 November 2016 Pages: 967 - 977
Costs of dementia in the Czech Republic Iva HolmerováJakub HortMichal Šteffl Original Paper 26 October 2016 Pages: 979 - 986
A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole D. CattelR. C. van KleefR. C. J. A. van Vliet Original Paper Open access 14 November 2016 Pages: 987 - 1000
Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies Hayley BennettJason GordonPhil McEwan Original Paper 01 November 2016 Pages: 1001 - 1011
Junior doctors’ medical specialty and practice location choice: simulating policies to overcome regional inequalities Pedro RamosHélio AlvesMaria A. Ferreira Original Paper 03 November 2016 Pages: 1013 - 1030
The impact of minimum wages on population health: evidence from 24 OECD countries Otto Lenhart Original Paper 14 November 2016 Pages: 1031 - 1039
Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth Josephine JacobMoritz LehneJochen Walker Original Paper 01 December 2016 Pages: 1041 - 1046
Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands Rudy DouvenKatalin KatonaVictoria Shestalova Original Paper Open access 27 February 2017 Pages: 1047 - 1064
